Evaluation once-daily levobunolol therapy increased intraocular pressure three-month double-masked randomized clinical trial once-daily ocular hypotensive efficacy levobunolol timolol patients open-angle glaucoma ocular hypertension patients levobunolol group patients timolol group three-month study period overall mean decrease intraocular pressure mm Hg levobunolol group mm Hg timolol group difference significant treatment groups effects mean heart rate blood pressure minimal data suggest daily effective treatment open-angle glaucoma ocular hypertension 